12 Jan 2022 Seizure study first step towards revealing which children are at risk of developing epilepsy Findings from an international genetic study involving the University of Melbourne means it may now be possible to predict which children are more likely to develop epilepsy later in life based on their genotype (the risk genes they may carry).
10 Jan 2022 Spleen function discovery could lead to better treatments for infectious diseases Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have discovered a new gene that plays an important role in the way the spleen functions, potentially leading to new treatments for infectious diseases.
3 Jan 2022 T cells fit to tackle Omicron, suggests new study Research from the University of Melbourne and Hong Kong University of Science and Technology (HKUST) has revealed T cells, one of the body’s key defences against COVID-19, are expected to be effective in mounting an immune response against Omicron despite its significantly higher mutations compared to previous variants of concern.
23 Dec 2021 Nasal spray to fight COVID-19 heads to clinical trial An at-home nasal spray treatment for COVID-19 will be put to the test by Melbourne biomedical researchers, as the University of Melbourne and Monash University receive $4.2 million to establish a six-month clinical trial lead by Northern Hospital in collaboration with Oxford University.
21 Dec 2021 University joins world-first consortium to fight global blindness Australian leaders in corneal bioengineering have collaborated to form BIENCO, a consortium to develop bioengineered eye tissue to treat corneal blindness.
19 Dec 2021 Retinal immune cells may hold key to preventing diabetes-related vision loss New research could form the basis for developing life-changing therapies that limit the impact of diabetic eye disease – a condition that could potentially affect some 1.7 million Australians, suffering from type 1 and type 2 diabetes.
16 Dec 2021 Minister updated on research into Omicron variant, AIID Foundation Partners Agreement signed Victoria’s Minister for Innovation, Medical Research and the Digital Economy Jaala Pulford today visited the Peter Doherty Institute for Infection and Immunity - one of the Foundation Partners of the new Australian Institute for Infectious Disease (AIID) along with the Burnet Institute and the University of Melbourne - to be briefed on the latest public health and research activities underway to better understand the COVID-19 Omicron variant.
16 Dec 2021 “Resilience and grit”: Top VCE students awarded scholarship After a challenging final two years of school spent mostly learning from home, the highest-achieving VCE students were today offered a Melbourne Chancellor’s Scholarship to study at the University of Melbourne.
15 Dec 2021 University of Melbourne and Hancock Prospecting team up to advance carbon conversion technology The University of Melbourne has entered into a multi-year partnership agreement with Hancock Prospecting Pty Ltd (HPPL) to develop CarbelecTM, an innovative technology that utilises electrolysis at low temperature to convert carbon dioxide (CO2) into reusable carbon and oxygen.
9 Dec 2021 Martine Letts to lead Asialink as new CEO The University of Melbourne and Asialink – Australia’s leading centre for creative engagement in Asia — have appointed a new Chief Executive Officer (CEO), Martine Letts.